Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $48.00 (+10.2%) * Over Last 12-Mos
Rating Score: 2.8 / 10   Percentile Rank: 26%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/26/2016 Cantor Fitzgerald New Coverage Hold
(N/A)
N/A
(N/A)
39.50 43.55 10.25% Details
10/20/2015 Credit Suisse Upgrade Neutral
(Underperform)
N/A
(N/A)
41.74 43.55 4.34% Details
Like GSK Ratings? Also take a look at PFE, MRK, INVA, BMY

GSK Ratings News